CINI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 2.637
AS - Asia 1.712
EU - Europa 1.251
SA - Sud America 113
AF - Africa 76
OC - Oceania 1
Totale 5.790
Nazione #
US - Stati Uniti d'America 2.604
SG - Singapore 591
CN - Cina 454
GB - Regno Unito 389
VN - Vietnam 331
DE - Germania 170
IT - Italia 126
HK - Hong Kong 123
FR - Francia 114
SE - Svezia 113
BR - Brasile 88
RU - Federazione Russa 84
IN - India 77
IE - Irlanda 53
UA - Ucraina 53
NL - Olanda 49
JP - Giappone 44
ZA - Sudafrica 39
EE - Estonia 34
KR - Corea 20
FI - Finlandia 18
BE - Belgio 16
CA - Canada 15
SC - Seychelles 15
MX - Messico 12
AR - Argentina 10
ID - Indonesia 10
CI - Costa d'Avorio 9
BD - Bangladesh 8
CH - Svizzera 7
IQ - Iraq 6
JO - Giordania 6
PH - Filippine 6
SA - Arabia Saudita 6
CO - Colombia 5
GR - Grecia 5
MA - Marocco 5
AT - Austria 4
MY - Malesia 4
RO - Romania 4
TH - Thailandia 4
TR - Turchia 4
PL - Polonia 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
PA - Panama 2
PE - Perù 2
PK - Pakistan 2
SN - Senegal 2
TG - Togo 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 5.790
Città #
Singapore 420
Fairfield 356
Southend 335
Ashburn 206
Santa Clara 190
Chandler 177
Woodbridge 158
Houston 141
Cambridge 136
San Jose 136
Wilmington 136
Seattle 126
Hong Kong 115
Ann Arbor 103
Ho Chi Minh City 80
Princeton 79
Hanoi 62
Beijing 60
Dallas 53
Dublin 53
Hefei 51
Nanjing 51
Boardman 47
Dong Ket 44
Tokyo 41
Lauterbourg 38
Padova 37
Westminster 37
Berlin 25
Los Angeles 25
Shenyang 25
Jinan 23
Dearborn 22
Jacksonville 22
Turin 21
Buffalo 20
Saint Petersburg 18
Bologna 16
Brussels 16
Hebei 16
Seoul 16
Helsinki 15
San Diego 15
New York 13
Changsha 12
Chicago 12
Frankfurt am Main 11
Hangzhou 10
Milan 10
Redondo Beach 10
Abidjan 9
Zhengzhou 9
Fuzhou 8
Jiaxing 8
São Paulo 8
Guangzhou 7
Haikou 7
Haiphong 7
Lanzhou 7
Nanchang 7
Amman 6
London 6
Norwalk 6
Tianjin 6
Atlanta 5
Bengaluru 5
Kunming 5
Redmond 5
Salt Lake City 5
San Francisco 5
Yubileyny 5
Bern 4
Bremen 4
Can Tho 4
Falls Church 4
Mahé 4
Medford 4
Mexico City 4
Montreal 4
Moscow 4
Mülheim 4
Ningbo 4
Ninh Bình 4
Nuremberg 4
Olalla 4
Orem 4
Paris 4
Quận Bình Thạnh 4
Rio de Janeiro 4
Wuhan 4
Xi'an 4
Amsterdam 3
Baghdad 3
Bexley 3
Boston 3
Chongqing 3
Council Bluffs 3
Elk Grove Village 3
Falkenstein 3
Johannesburg 3
Totale 4.084
Nome #
Diagnostic Accuracy of a New d -Dimer Assay (Sclavo Auto d -Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients 202
Age and gender specific cut-off values to improve the performance of D: -dimer assays to predict the risk of venous thromboembolism recurrence. 193
Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal. 191
A new rapid bedside assay for D-dimer measurement (Simplify D-dimer) in the diagnostic work-up for deep vein thrombosis. 190
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study 182
G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease. 172
D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis 170
Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs. 166
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. 164
High plasma levels of factor VIII and risk of recurrence of venous thromboembolism 161
Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study 160
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. 158
D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome 158
Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs 156
D-dimer and factor VIII are independent risk factors for recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. 155
Incidence and clinical outcomes of heparin-induced thrombocytopenia: 11 year experience in a tertiary care university hospital 151
Evaluation of a chemiluminescent immunoassay, the HemosIL AcuStar D-Dimer, in outpatients with clinically suspected deep venous thrombosis 149
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis. 148
Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis. 146
Measurement of factor XIII (FXIII) activity by an automatic ammonia release assay using iodoacetamide blank-procedure: no more overestimation in the low activity range and better detection of severe FXIII deficiencies 146
Thrombin generation and intracranial atherosclerotic disease in patients with a transient ischaemic attack 144
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer units 144
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms 141
Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. 139
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. 139
Rivaroxaban in the Treatment of Heparin-Induced Thrombocytopenia 139
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: a prospective, randomised study comparing two doses of parnaparin (BAFLUX study). 137
The influence of VKORC1 3730 G > A polymorphism on warfarin dose: reply. 134
Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin. 132
Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels. 130
D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. 129
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 128
Thrombophilic risk factors and peripheral arterial disease severity. 124
Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil D-dimer HS 500, in patients with clinically suspected venous thromboembolism. 116
The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis 114
No early signs of atherosclerotic alterations in carriers of inherited thrombophilia. 114
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. 102
Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry 84
null 80
The role of D-dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients. 79
Venous Thromboembolism in Women of Childbearing Age: Insights from the START Registry 62
Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. 61
Totale 5.890
Categoria #
all - tutte 15.439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.439


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 16 88
2021/2022603 79 32 46 27 62 41 21 43 17 51 61 123
2022/2023649 106 108 26 97 42 49 14 37 84 20 47 19
2023/2024114 5 36 17 8 13 7 5 5 1 4 5 8
2024/2025901 19 152 54 40 250 42 56 7 3 67 13 198
2025/20261.587 90 152 193 108 239 116 148 101 286 99 55 0
Totale 5.890